Literature DB >> 20622073

Neuroscience and heart-brain medicine: the year in review.

David S Goldstein1.   

Abstract

Important recent publications in the area of neuroscience and heart-brain medicine center largely around three topics: (1) mechanisms of cardiac sympathetic denervation in Parkinson disease, (2) cytoplasmic monoamine metabolites as autotoxins, and (3) the validity of power spectral analysis of heart rate variability to indicate cardiac sympathetic tone. Findings by Orimo et al support a centripetal, retrograde pathogenetic process involving alpha-synuclein deposition and degeneration of cardiac noradrenergic neurons in Parkinson disease. Several studies suggest that processes increasing cytoplasmic monoamines lead to neuronal loss from auto-oxidation or enzymatic oxidation. Lack of correlation between commonly used indices from power spectral analysis of heart rate variability and cardiac norepinephrine spillover casts doubt on the validity of power spectral analysis to indicate cardiac sympathetic tone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20622073      PMCID: PMC4164387          DOI: 10.3949/ccjm.77.s3.06

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  25 in total

1.  Amine oxidase and amine metabolism.

Authors:  H BLASCHKO
Journal:  Pharmacol Rev       Date:  1952-12       Impact factor: 25.468

2.  Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine.

Authors:  William J Burke; Vijaya B Kumar; Neeraj Pandey; W Michael Panneton; Qi Gan; Mark W Franko; Mark O'Dell; Shu Wen Li; Yi Pan; Hyung D Chung; James E Galvin
Journal:  Acta Neuropathol       Date:  2007-10-27       Impact factor: 17.088

3.  Profound cardiac sympathetic denervation occurs in Parkinson disease.

Authors:  Takeshi Amino; Satoshi Orimo; Yoshinori Itoh; Atsushi Takahashi; Toshiki Uchihara; Hidehiro Mizusawa
Journal:  Brain Pathol       Date:  2005-01       Impact factor: 6.508

4.  Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves.

Authors:  Ricardo A Peña-Silva; Jordan D Miller; Yi Chu; Donald D Heistad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

5.  Alpha-synuclein overexpression increases cytosolic catecholamine concentration.

Authors:  Eugene V Mosharov; Roland G W Staal; Jordi Bové; Delphine Prou; Anthonia Hananiya; Dmitriy Markov; Nathan Poulsen; Kristin E Larsen; Candace M H Moore; Matthew D Troyer; Robert H Edwards; Serge Przedborski; David Sulzer
Journal:  J Neurosci       Date:  2006-09-06       Impact factor: 6.167

6.  Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication.

Authors:  Amanda Singleton; Katrina Gwinn-Hardy; Yehonotan Sharabi; Sheng-Ting Li; Courtney Holmes; Raghuveer Dendi; John Hardy; Andrew Singleton; Anthony Crawley; David S Goldstein
Journal:  Brain       Date:  2004-01-21       Impact factor: 13.501

7.  ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia.

Authors:  Dagmar Galter; Silvia Buervenich; Andrea Carmine; Maria Anvret; Lars Olson
Journal:  Neurobiol Dis       Date:  2003-12       Impact factor: 5.996

8.  QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder.

Authors:  Mathias Baumert; Gavin W Lambert; Tye Dawood; Elisabeth A Lambert; Murray D Esler; Mariee McGrane; David Barton; Eugene Nalivaiko
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-07-03       Impact factor: 4.733

9.  Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.

Authors:  B A Kingwell; J M Thompson; D M Kaye; G A McPherson; G L Jennings; M D Esler
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

10.  Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.

Authors:  Dennis W Dickson; Hiroshige Fujishiro; Anthony DelleDonne; Joshua Menke; Zeshan Ahmed; Kevin J Klos; Keith A Josephs; Roberta Frigerio; Melinda Burnett; Joseph E Parisi; J Eric Ahlskog
Journal:  Acta Neuropathol       Date:  2008-02-09       Impact factor: 17.088

View more
  4 in total

1.  Determinants of exercise capacity in dilated cardiomyopathy: a prospective, explorative cohort study.

Authors:  Wilhelm Grander; Bernhard Koller; Johannes Schwaiger; Herbert Tilg; Martin W Dünser
Journal:  Wien Klin Wochenschr       Date:  2012-08-10       Impact factor: 1.704

2.  α-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits.

Authors:  Penelope J Hallett; Jesse R McLean; Andrew Kartunen; J William Langston; Ole Isacson
Journal:  Neurobiol Dis       Date:  2012-04-19       Impact factor: 5.996

3.  Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteins.

Authors:  José Luis González-Guerra; Inma Castilla-Cortazar; Gabriel A Aguirre; Úrsula Muñoz; Irene Martín-Estal; Elena Ávila-Gallego; Miriam Granado; Juan E Puche; Ángel Luis García-Villalón
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

Review 4.  Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications.

Authors:  Honglei Chen; Edward A Burton; G Webster Ross; Xuemei Huang; Rodolfo Savica; Robert D Abbott; Alberto Ascherio; John N Caviness; Xiang Gao; Kimberly A Gray; Jau-Shyong Hong; Freya Kamel; Danna Jennings; Annette Kirshner; Cindy Lawler; Rui Liu; Gary W Miller; Robert Nussbaum; Shyamal D Peddada; Amy Comstock Rick; Beate Ritz; Andrew D Siderowf; Caroline M Tanner; Alexander I Tröster; Jing Zhang
Journal:  Environ Health Perspect       Date:  2013-08-09       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.